Bone marrow microenvironment signatures associate with patient survival after guadecitabine and atezolizumab therapy in HMA-resistant MDS
在HMA耐药的MDS患者中,骨髓微环境特征与接受guadecitabine和atezolizumab治疗后的生存率相关。
期刊:
影响因子:
doi:10.1101/2024.11.08.622670
Jang, H Josh; Urrutia, Guillermo; Orskov, Andreas Due; Kim, Hyeon Jin; Nelson, Seth A; Nguyen, Anh Van; Lee, Hyein; Burgos, Ryan S; Johnson, Benjamin K; Wegener, Marc; Becker, Katelyn; Adams, Marie; Sheridan, Rachael; Ramjan, Zachary H; Givan, Scott A; Zebley, Caitlin C; Youngblood, Benjamin A; Issa, Jean-Pierre J; Topper, Michael J; Baylin, Stephen B; Baer, Maria R; Triche, Timothy J; O'Connell, Casey L; Gronbaek, Kirsten; Jones, Peter A